
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements
Josh Tycko, Michael Wainberg, Georgi K. Marinov, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 128
Josh Tycko, Michael Wainberg, Georgi K. Marinov, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 128
Showing 1-25 of 128 citing articles:
Multiplexed CRISPR technologies for gene editing and transcriptional regulation
Nicholas S. McCarty, Alicia E. Graham, Lucie Studená, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 401
Nicholas S. McCarty, Alicia E. Graham, Lucie Studená, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 401
CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 299
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 299
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”
Katia Grillone, Caterina Riillo, Francesca Scionti, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 198
Katia Grillone, Caterina Riillo, Francesca Scionti, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 198
A new era in functional genomics screens
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 184
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 184
Optimization of AsCas12a for combinatorial genetic screens in human cells
Peter C. DeWeirdt, Kendall R Sanson, Annabel K. Sangree, et al.
Nature Biotechnology (2020) Vol. 39, Iss. 1, pp. 94-104
Open Access | Times Cited: 160
Peter C. DeWeirdt, Kendall R Sanson, Annabel K. Sangree, et al.
Nature Biotechnology (2020) Vol. 39, Iss. 1, pp. 94-104
Open Access | Times Cited: 160
High-throughput single-cell chromatin accessibility CRISPR screens enable unbiased identification of regulatory networks in cancer
Sarah E. Pierce, Jeffrey M. Granja, William J. Greenleaf
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
Sarah E. Pierce, Jeffrey M. Granja, William J. Greenleaf
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
Genome-Wide Analysis of Human Long Noncoding RNAs: A Provocative Review
Chris P. Ponting, Wilfried Haerty
Annual Review of Genomics and Human Genetics (2022) Vol. 23, Iss. 1, pp. 153-172
Open Access | Times Cited: 82
Chris P. Ponting, Wilfried Haerty
Annual Review of Genomics and Human Genetics (2022) Vol. 23, Iss. 1, pp. 153-172
Open Access | Times Cited: 82
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Yimin Du, Yanfei Liu, Jiaxin Hu, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100854-100854
Open Access | Times Cited: 57
Yimin Du, Yanfei Liu, Jiaxin Hu, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100854-100854
Open Access | Times Cited: 57
Direct characterization of cis-regulatory elements and functional dissection of complex genetic associations using HCR–FlowFISH
Steven K. Reilly, Sager J. Gosai, Alan Gutierrez, et al.
Nature Genetics (2021) Vol. 53, Iss. 8, pp. 1166-1176
Open Access | Times Cited: 65
Steven K. Reilly, Sager J. Gosai, Alan Gutierrez, et al.
Nature Genetics (2021) Vol. 53, Iss. 8, pp. 1166-1176
Open Access | Times Cited: 65
Identification of non-coding silencer elements and their regulation of gene expression
Baoxu Pang, Jan Hendrik van Weerd, Feija L. Hamoen, et al.
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 6, pp. 383-395
Open Access | Times Cited: 62
Baoxu Pang, Jan Hendrik van Weerd, Feija L. Hamoen, et al.
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 6, pp. 383-395
Open Access | Times Cited: 62
CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
Yau-Tuen Chan, Yuanjun Lu, Junyu Wu, et al.
Theranostics (2022) Vol. 12, Iss. 7, pp. 3329-3344
Open Access | Times Cited: 55
Yau-Tuen Chan, Yuanjun Lu, Junyu Wu, et al.
Theranostics (2022) Vol. 12, Iss. 7, pp. 3329-3344
Open Access | Times Cited: 55
Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2
Annabel K. Sangree, Audrey L Griffith, Zsofia M Szegletes, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Annabel K. Sangree, Audrey L Griffith, Zsofia M Szegletes, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches
Xiaolong Cheng, Zexu Li, Ruocheng Shan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Xiaolong Cheng, Zexu Li, Ruocheng Shan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Unlocking the potential of non-coding RNAs in cancer research and therapy
Kalyan Ram Uppaluri, Hima Jyothi Challa, Ashish Gaur, et al.
Translational Oncology (2023) Vol. 35, pp. 101730-101730
Open Access | Times Cited: 34
Kalyan Ram Uppaluri, Hima Jyothi Challa, Ashish Gaur, et al.
Translational Oncology (2023) Vol. 35, pp. 101730-101730
Open Access | Times Cited: 34
Multicenter integrated analysis of noncoding CRISPRi screens
David Yao, Josh Tycko, Jin Woo Oh, et al.
Nature Methods (2024) Vol. 21, Iss. 4, pp. 723-734
Open Access | Times Cited: 17
David Yao, Josh Tycko, Jin Woo Oh, et al.
Nature Methods (2024) Vol. 21, Iss. 4, pp. 723-734
Open Access | Times Cited: 17
Genome-scale pan-cancer interrogation of lncRNA dependencies using CasRx
Juán José Montero, Riccardo Trozzo, M C Sugden, et al.
Nature Methods (2024) Vol. 21, Iss. 4, pp. 584-596
Open Access | Times Cited: 15
Juán José Montero, Riccardo Trozzo, M C Sugden, et al.
Nature Methods (2024) Vol. 21, Iss. 4, pp. 584-596
Open Access | Times Cited: 15
PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics
Sundaram Acharya, Asgar Hussain Ansari, P.K. Das, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Sundaram Acharya, Asgar Hussain Ansari, P.K. Das, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations
Chris C.‐S. Hsiung, Caroline Wilson, Nicholas A. Sambold, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 13
Chris C.‐S. Hsiung, Caroline Wilson, Nicholas A. Sambold, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 13
Development of compact transcriptional effectors using high-throughput measurements in diverse contexts
Josh Tycko, Mike V. Van, Aradhana, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 11
Josh Tycko, Mike V. Van, Aradhana, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 11
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10
Engineering strategies to safely drive CAR T-cells into the future
Matteo Rossi, Eytan Breman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Matteo Rossi, Eytan Breman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Exploring the synthetic biology potential of bacteriophages for engineering non-model bacteria
Eveline‐Marie Lammens, Pablo I. Nikel, Rob Lavigne
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Eveline‐Marie Lammens, Pablo I. Nikel, Rob Lavigne
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
Shuquan Rao, Yao Yao, Daniel E. Bauer
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Shuquan Rao, Yao Yao, Daniel E. Bauer
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Challenges and Strategies in Ascribing Functions to Long Noncoding RNAs
Yang Zhao, Hongqi Teng, Fan Yao, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1458-1458
Open Access | Times Cited: 54
Yang Zhao, Hongqi Teng, Fan Yao, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1458-1458
Open Access | Times Cited: 54
Quantification of Cas9 binding and cleavage across diverse guide sequences maps landscapes of target engagement
Evan A. Boyle, Winston R. Becker, Hua Bai, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 48
Evan A. Boyle, Winston R. Becker, Hua Bai, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 48